Creavo’s Magnetocardiography (MCG) technology

Creavo’s MCG technology

Putting game-changing technology in your hands

MCG (magnetocardiography) has existed for decades, but only Creavo has managed to make this deployable at the patient’s bedside. Creavo believes the device has the power to transform the way busy hospital departments operate by significantly reducing disruption to patient care.

The first new imaging modality since MRI…”

Prof Mark Kearney,
BHF Professor of Cardiology

Putting game-changing technology
in your hands

MCG (magnetocardiography) has existed for decades, but only Creavo has managed to make this deployable at the patient’s bedside. Creavo believes the device has the power to transform the way busy hospital departments operate by significantly reducing disruption to patient care.

The first new imaging
modality since MRI… “

Prof Mark Kearney,
BHF Professor of Cardiology

Putting game-changing technology in your hands

MCG (magnetocardiography) has existed for decades, but only Creavo has managed to make this deployable to the patient’s bedside. Creavo believes the device has the power to transform the way busy hospital departments operate by significantly reducing disruption to patient care.

The first new imaging
modality since MRI… “

Prof Mark Kearney,
BHF Professor of Cardiology

*For investigational use only, not approved for sale

Rule-out: identifying the absence of active ischaemia

Corsens® generates a magnetic field map and MCG measurements which aid healthcare professionals to differentiate rapidly between a non-ischaemic heart and one experiencing active ischaemia. Patients without active ischaemia who are still experiencing chest pain can then be triaged to a more appropriate care pathway without delay.

The unique advantages of Creavo’s Magnetocardiography (MCG) Technology

Creavo’s magnetocardiography (MCG) technology detects and analyses the minute magnetic signals associated with the heart’s electrical activity via a non-invasive scan within a few minutes. The scan results aid healthcare professionals to rule out active Ischaemia in patients presenting with symptoms consistent with those of acute coronary syndrome.

The unique advantages of Creavo’s Magnetocardiography (MCG) Technology

Creavo’s magnetocardiography (MCG) technology detects and analyses the minute magnetic signals associated with the heart’s electrical activity via a non-invasive scan within a few minutes. The scan results aid healthcare professionals to rule out active Ischaemia in patients presenting with symptoms consistent with those of acute coronary syndrome.

Other clinical applications

Ischaemia

Myocardial ischaemia is a condition where blood flow to the heart is reduced. This causes a lack of oxygen which can lead to a ‘heart attack’. Corsens® aids healthcare professionals in ruling out active Ischaemia in patients presenting with symptoms consistent with those of acute coronary syndrome in the emergency department.

Arrhythmia

Arrhythmia is a disruption of the heart’s normal, regular rhythm. Some arrhythmias, particularly those associated with coronary heart disease, may be life threatening and result in sudden cardiac death (SCD). SCD, both in patients with known risk factors and in people who have had no previous symptoms, is a major public health problem. MCG has the potential to help researchers, and ultimately clinicians, identify those most at risk of SCD, resulting in appropriate, life saving treatments. MCG may also prove useful in helping to identify patients most likely to benefit from expensive treatments for both arrhythmias and severe heart failure.

Are you interested in seeing Corsens® in action?